LR Kelland
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
- Toxicology top 5%
Papers in
- Oncology 25
- Metal complexes synthesis and properties 14
- Drug Transport and Resistance Mechanisms 5
- Cancer Treatment and Pharmacology 4
-
- Ferrocene Chemistry and Applications 5
- Click Chemistry and Applications 4
- Co-authors
- Paul Rogers (3 shared papers)Swee Y. Sharp (3 shared papers)Paul Workman (1 shared paper)Timothy G. Myers (1 shared paper)Kenneth R. Harrap (3 shared papers)Nicholas P. Farrell (2 shared papers)KR Harrap (4 shared papers)John D. Roberts (1 shared paper)
- Journals
- British Journal of Cancer (13 papers)JNCI Journal of the National Cancer Institute (1 paper)Medicinal Chemistry Research (1 paper)International Journal of Oncology (1 paper)Toxicology in Vitro (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
LR Kelland
36 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 96
- Oncology 940
- Toxicology 59
- Organic Chemistry 447
- Molecular Biology 846
- Cancer Research 126
Countries citing papers authored by LR Kelland
This map shows the geographic impact of LR Kelland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LR Kelland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LR Kelland more than expected).
Fields of papers citing papers by LR Kelland
This network shows the impact of papers produced by LR Kelland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LR Kelland. The network helps show where LR Kelland may publish in the future.
Co-authors
The 25 scholars most cited alongside LR Kelland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 313 | |
| 2 | 2004 | 286 | |
| 3 | Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. | 1992 | 164 |
| 4 | 1992 | 156 | |
| 5 | 2000 | 124 | |
| 6 | 1993 | 103 | |
| 7 | 2000 | 100 | |
| 8 | 1998 | 64 | |
| 9 | Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. | 1995 | 49 |
| 10 | 1990 | 46 | |
| 11 | Telomerase as an anti-cancer target: current status and future prospects. | 1999 | 38 |
| 12 | 1999 | 38 | |
| 13 | 1996 | 36 | |
| 14 | In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells. | 1994 | 34 |
| 15 | 1995 | 33 | |
| 16 | Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. | 1996 | 32 |
| 17 | Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines. | 1994 | 29 |
| 18 | 1996 | 28 | |
| 19 | In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line. | 2001 | 28 |
| 20 | Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. | 1999 | 27 |
About LR Kelland
LR Kelland is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Nutrition and Dietetics and Obstetrics and Gynecology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (14 papers), Ferrocene Chemistry and Applications (5 papers), DNA and Nucleic Acid Chemistry (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Cancer Treatment and Pharmacology (4 papers), Trace Elements in Health (4 papers), Click Chemistry and Applications (4 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Oncology (940 citations), Toxicology (59 citations), Organic Chemistry (447 citations), Molecular Biology (846 citations) and Cancer Research (126 citations). LR Kelland has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Paul Rogers, Swee Y. Sharp, Paul Workman, Timothy G. Myers, Kenneth R. Harrap, Nicholas P. Farrell, KR Harrap, John D. Roberts, G Abel and Prakash Mistry. Their work appears in journals such as British Journal of Cancer, JNCI Journal of the National Cancer Institute, Medicinal Chemistry Research, International Journal of Oncology and Toxicology in Vitro.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.